HeartSciences Total Long Term Liabilities 2022-2025 | HSCS
HeartSciences total long term liabilities from 2022 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
| HeartSciences Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $1 |
| 2022 | $5 |
| 2021 | $3 |
| HeartSciences Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2025-01-31 | $0 |
| 2024-10-31 | $0 |
| 2024-07-31 | $1 |
| 2024-04-30 | $0 |
| 2024-01-31 | $0 |
| 2023-10-31 | $0 |
| 2023-07-31 | $1 |
| 2023-04-30 | $1 |
| 2023-01-31 | $2 |
| 2022-10-31 | $1 |
| 2022-07-31 | $1 |
| 2022-04-30 | $5 |
| 2022-01-31 | |
| 2021-10-31 | |
| 2021-07-31 | |
| 2021-04-30 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.000B |
| Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.328B | 59.20 |
| Hims & Hers Health (HIMS) | United States | $12.250B | 127.28 |
| Tempus AI (TEM) | United States | $10.726B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.629B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.081B | 63.76 |
| Hinge Health (HNGE) | United States | $3.147B | 0.00 |
| Privia Health (PRVA) | United States | $2.800B | 191.42 |
| Enovis (ENOV) | United States | $1.753B | 9.77 |
| Schrodinger (SDGR) | United States | $1.680B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 25.64 |
| Azenta (AZTA) | United States | $1.298B | 60.34 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.644B | 0.00 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.584B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 170.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 793.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.50 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |